Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 352

Related Citations for PubMed (Select 21738027)

1.

When does it end? Attention-deficit/hyperactivity disorder in the middle aged and older populations.

Manor I, Rozen S, Zemishlani Z, Weizman A, Zalsman G.

Clin Neuropharmacol. 2011 Jul-Aug;34(4):148-54. doi: 10.1097/WNF.0b013e3182206dc1.

PMID:
21738027
2.

A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorder.

Rösler M, Fischer R, Ammer R, Ose C, Retz W.

Eur Arch Psychiatry Clin Neurosci. 2009 Mar;259(2):120-9. doi: 10.1007/s00406-008-0845-4. Epub 2009 Jan 22. Erratum in: Eur Arch Psychiatry Clin Neurosci. 2009 Sep;259(6):368.

PMID:
19165529
3.
4.

Attention-deficit/hyperactivity disorder with obstructive sleep apnea: a treatment outcome study.

Huang YS, Guilleminault C, Li HY, Yang CM, Wu YY, Chen NH.

Sleep Med. 2007 Jan;8(1):18-30. Epub 2006 Dec 6.

PMID:
17157069
5.

Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypes.

Chou WJ, Chou MC, Tzang RF, Hsu YC, Gau SS, Chen SJ, Wu YY, Huang YF, Liang HY, Cheng H.

Psychiatry Clin Neurosci. 2009 Apr;63(2):167-75. doi: 10.1111/j.1440-1819.2009.01937.x.

PMID:
19335386
6.

Association of Parkinson's disease with symptoms of attention deficit hyperactivity disorder in childhood.

Walitza S, Melfsen S, Herhaus G, Scheuerpflug P, Warnke A, Müller T, Lange KW, Gerlach M.

J Neural Transm Suppl. 2007;(72):311-5.

PMID:
17982908
8.

Efficacy of reboxetine in the treatment of attention-deficit/hyperactivity disorder in boys with intolerance to methylphenidate: an open-label, 8-week, methylphenidate-controlled trial.

Cohen-Yavin I, Yoran-Hegesh R, Strous RD, Kotler M, Weizman A, Spivak B.

Clin Neuropharmacol. 2009 Jul-Aug;32(4):179-82. doi: 10.1097/WNF.0b013e318183796d.

PMID:
19644227
9.

Methylphenidate in the treatment of female adolescents with cooccurrence of attention deficit/hyperactivity disorder and borderline personality disorder: a preliminary open-label trial.

Golubchik P, Sever J, Zalsman G, Weizman A.

Int Clin Psychopharmacol. 2008 Jul;23(4):228-31. doi: 10.1097/YIC.0b013e3282f94ae2.

PMID:
18446088
10.

Subtype differences in adults with attention-deficit/hyperactivity disorder (ADHD) with regard to ADHD-symptoms, psychiatric comorbidity and psychosocial adjustment.

Sobanski E, Brüggemann D, Alm B, Kern S, Philipsen A, Schmalzried H, Hesslinger B, Waschkowski H, Rietschel M.

Eur Psychiatry. 2008 Mar;23(2):142-9. Epub 2007 Nov 19.

PMID:
18024089
11.

A dose-response study of OROS methylphenidate in children with attention-deficit/hyperactivity disorder.

Stein MA, Sarampote CS, Waldman ID, Robb AS, Conlon C, Pearl PL, Black DO, Seymour KE, Newcorn JH.

Pediatrics. 2003 Nov;112(5):e404.

PMID:
14595084
12.
13.

Once-daily multilayer-release methylphenidate in a double-blind, crossover comparison to immediate-release methylphenidate in children with attention-deficit/hyperactivity disorder.

Weiss M, Hechtman L, Turgay A, Jain U, Quinn D, Ahmed TS, Yates T, Reiz JL, Donnelly GA, Harsanyi Z, Darke AC.

J Child Adolesc Psychopharmacol. 2007 Oct;17(5):675-88.

PMID:
17979587
14.
16.

Methylphenidate treatment in children with attention deficit hyperactivity disorder and comorbid social phobia.

Golubchik P, Sever J, Weizman A.

Int Clin Psychopharmacol. 2014 Jul;29(4):212-5. doi: 10.1097/YIC.0000000000000029.

17.

Severity but not comorbidities predicts response to methylphenidate in adults with attention-deficit/hyperactivity disorder: results from a naturalistic study.

Victor MM, Rovaris DL, Salgado CA, Silva KL, Karam RG, Vitola ES, Picon FA, Contini V, Guimarães-da-Silva PO, Blaya-Rocha P, Belmonte-de-Abreu PS, Rohde LA, Grevet EH, Bau CH.

J Clin Psychopharmacol. 2014 Apr;34(2):212-7. doi: 10.1097/JCP.0000000000000091.

PMID:
24577256
18.

An open-label trial of OROS methylphenidate in adults with late-onset ADHD.

Biederman J, Mick E, Spencer T, Surman C, Hammerness P, Doyle R, Dougherty M, Aleardi M, Schweitzer K.

CNS Spectr. 2006 May;11(5):390-6.

PMID:
16641844
19.

[Attention deficit disorder: multidisciplinary observational study over 1 year].

Chambry J, Billard C, Guinard M, Lacaze E, Idiart ME, Delteil-Pinton F, Cohen de Lara A.

Encephale. 2011 Jun;37(3):180-90. doi: 10.1016/j.encep.2011.01.012. Epub 2011 Mar 5. French.

PMID:
21703433
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk